Fig. 6: Magnesium supplementation prevents the progression of TUSC3-induced intellectual disability phenotypes before symptoms manifest. | Nature Communications

Fig. 6: Magnesium supplementation prevents the progression of TUSC3-induced intellectual disability phenotypes before symptoms manifest.

From: TUSC3 regulates ERMA-mediated Mg2+ uptake for synaptic function and neurodevelopment

Fig. 6: Magnesium supplementation prevents the progression of TUSC3-induced intellectual disability phenotypes before symptoms manifest.

a Experimental timeline. Four-week-old mice received chronic magnesium supplementation via drinking water containing MgT (910 mg/kg/day) for 42 days, followed by behavioral analysis. Created with BioRender.com. b, c Cognitive performance of MgT-treated WT and TUSC3 KO mice assessed in the Y-maze (b) and NOR test (c). d Stress-coping ability evaluated using the TST. e, f Social behavior assessed in the social interaction (e) and social novelty preference (f) tests (left). Time spent in each chamber (middle) and sniffing time (right) were measured. gh Representative western blot of hippocampal tissues from WT and TUSC3 KO mice treated with vehicle or MgT (g). Quantification of indicated protein levels (h) (n = 3). i, j Representative confocal images of GluA1 immunohistochemistry in the CA1 (i) and CA3 (j) hippocampal regions from WT and TUSC3 KO mice treated with vehicle or MgT (n = 3). Scale bar: 50 μm. In these experiments, 10-week-old mice were used: WT: 8 (4 F, 4 M); WT + MgT: 8 (4 F, 4 M); KO: 6 (3 F, 3 M); KO + MgT: 8 (5 F, 3 M). Two-way ANOVA with Tukey’s post hoc multiple comparison test. All data are represented as mean ± S.E.M. Source data are provided as a Source data file.

Back to article page